Serge Saxonov was Appointed as Chief Executive Officer at 10X Genomics

Date of management change: November 15, 2012 

What Happened?

Pleasanton, CA-based 10X Genomics Appointed Serge Saxonov as Chief Executive Officer

 

About the Company

10X Genomics meets the critical need for long range, structural and cellular information, with an innovative system that transforms short-read sequencing technologies. Our Chromium™ System supports comprehensive genomics and high-throughput single cell transcriptomics. It enables researchers to discover previously inaccessible genomic information at unprecedented scale, including phased structural variants, phased single nucleotide variants, and dynamic gene expression of individual cells—while leveraging their existing sequencing systems and workflows.

 

About the Person

Serge Saxonov co-founded 10x Genomics in 2012 and has served as the CEO since its inception. Prior to 10x Genomics, Serge was VP of Applications at QuantaLife, where he was responsible for building content, driving new applications, and identifying key diagnostics opportunities for the core ddPCR technology. Before QuantaLife, Serge was Founding Architect and Director of R&D at 23andMe.   There he defined the initial conception of the product, built many elements of the technology, and drove strategy and execution of R&D functions as the company scaled. Serge received a Ph.D. in biomedical informatics from Stanford University and an A.B. in applied mathematics and biology from Harvard University.  

 

Info Source

Press Release

 
 

Other IT executives who recently changed jobs as well: Kamarei Golbie, Hass Wilfred, Sinha Manish, Ignacio Teresa, Yaffa Marci, Serio Benjamin, Magnussen Eric, Demuth Kathy, Marts John, Schukle Karen, Daniels Douglas

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.